Loading...
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Recruitment of myeloid-derived suppressor cells (MDSCs) into tumors induces local immunosuppression in carcinomas. Here, we assessed whether SX-682, an orally bioavailable small-molecule inhibitor of CXCR1 and CXCR2, could block tumor MDSC recruitment and enhance T cell activation and antitumor immu...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483637/ https://ncbi.nlm.nih.gov/pubmed/30944253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.126853 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|